Chromatin and transcriptional regulatory factors that initiate and stabilize memory CD8 T cell development

启动和稳定记忆 ​​CD8 T 细胞发育的染色质和转录调节因子

基本信息

  • 批准号:
    10683275
  • 负责人:
  • 金额:
    $ 67.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT Project 2 (Pipkin) Activation of naive CD8 T cells during intracellular infections rapidly induces chromatin remodeling and transcriptional reprogramming that results in the differentiation of memory (TMEM) CTLs that provide long-term immunity. We discovered that the transcription factor (TF) Runx3 instigates chromatin accessibility of TMEM- associated cis-regulatory regions in naive cells during initial T cell receptor (TCR) stimulation, and is essential for the differentiation of both circulating and tissue resident TMEM CTLs. Runx3 activates transcriptional circuits that establishes nascent CTLs, represses alternative cell fates and prevents terminal CTL differentiation. Using mass spectrometry we identified all subunits of the NuRD/HDAC complex in association with Runx3. In addition, we conducted a pooled, RNA interference (RNAi) -mediated, loss-of-function screen in CD8 T cells responding to viral infection that targeted all mammalian chromatin regulator factors (CRFs, 312 genes). This revealed that deficiency in multiple individual NuRD/HDAC complex subunits impaired memory precursor CTL differentiation, similar to Runx3 loss-of-function. In addition, multiple subunits of the BAF-family of nucleosome remodelers and its collaborator Chd7, which is mutated in a human immunodeficiency, were essential for initiating very early aspects of CTL differentiation and driving terminal differentiation. To gain insight into early aspects of CTL development, we used a single cell RNA-seq (scRNA-seq) approach and performed computational trajectory analyses which identified common, and then branching developmental pathways from naive CD8s that lead toward effector and memory cell fates. In part, we confirmed these pathways operationally using Blimp1-YFP reporter alleles and adoptive transfer experiments. In the current application, we propose to build on these results to elucidate how CRFs and TFs reprogram chromatin structure during naive cell activation and early establishment of effector and memory-like developmental paths. Specifically, we will define how Runx3 and NuRD/HDAC complexes remodel chromatin structure to establish initial TMEM transcriptional programs (Aim 1). We will elucidate how hierarchical functions of Runx3, Ets1, Blimp1 and Bcl6 regulate the divergence of Blimp1hi and Blimp1lo effector- and memory-like developmental paths, and use an in vivo conditional RNAi approach in naive CD8s to screen all T cell-expressed TFs (1,751 genes) to identify their roles in this process during viral infection (Aim 2). Finally, we will integrate these analyses with how BAF and Chd7 remodelers govern nucleosome organization in cis-regulatory regions that control transcriptional reprograming during early CTL differentiation (Aim 3). These studies integrate synergistically with analogous approaches addressing the roles of CRFs and TFs in TFH differentiation and function (Crotty, Project 1), and how they function at later times to maintain the differentiation and function of specific CD4 and CD8 TMEM cell subsets that persist following infections, and that infiltrate tumors (Goldrath, Project 3). 1
项目总结/摘要 项目2(Pipkin) 细胞内感染期间初始CD 8 T细胞的活化迅速诱导染色质重塑, 转录重编程,导致记忆(TMEM)CTL的分化, 免疫力我们发现,转录因子(TF)Runx 3可促进TMEM-1的染色质可及性。 在初始T细胞受体(TCR)刺激期间,初始细胞中的相关顺式调节区,并且是必需的 用于区分循环和组织驻留TMEM CTL。Runx 3激活转录回路 其建立新生CTL,抑制替代细胞命运并阻止终末CTL分化。使用 通过质谱分析,我们鉴定了与Runx 3相关的NuRD/HDAC复合物的所有亚基。此外,本发明还提供了一种方法, 我们在CD 8 T细胞中进行了一项合并的RNA干扰(RNAi)介导的功能丧失筛选, 针对所有哺乳动物染色质调节因子(CRF,312个基因)的病毒感染。这揭示了 多个单独的NuRD/HDAC复合物亚单位的缺陷损害了记忆前体CTL分化, 类似于Runx 3功能丧失。此外,BAF家族的核小体重塑和 它的合作者Chd 7在人类免疫缺陷中发生突变, CTL分化和驱动终末分化方面。深入了解CTL的早期方面 开发中,我们使用了单细胞RNA-seq(scRNA-seq)方法,并进行了计算轨迹 这些分析确定了共同的,然后从幼稚的CD 8细胞分支的发育途径, 效应细胞和记忆细胞的命运在某种程度上,我们使用Blimp 1-YFP在操作上证实了这些途径。 报告等位基因和过继转移实验。在当前的应用中,我们建议建立在这些结果的基础上 阐明CRF和TF如何在幼稚细胞活化和早期细胞凋亡过程中重编程染色质结构, 效应器和记忆样发育路径的建立。具体来说,我们将定义Runx 3和 NuRD/HDAC复合物重塑染色质结构以建立初始TMEM转录程序(目的1)。 我们将阐明Runx 3、Ets 1、Blimp 1和Bcl 6的分级功能如何调节Blimp 1hi的趋异 和Blimp 1 lo效应和记忆样发育途径,并使用体内条件性RNAi方法, 幼稚CD 8筛选所有T细胞表达的TF(1,751个基因),以确定它们在病毒感染过程中在这一过程中的作用。 感染(目标2)。最后,我们将把这些分析与BAF和Chd 7改造如何治理 在早期CTL过程中控制转录重编程的顺式调节区中的核小体组织 差异化(目标3)。这些研究与类似的方法协同整合, CRF和TF在TFH分化和功能中的作用(Crotty,项目1),以及它们在以后的时间如何发挥作用, 维持特异性CD 4和CD 8 TMEM细胞亚群的分化和功能, 感染和浸润肿瘤(Goldrath,项目3)。 1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew Eugene Pipkin其他文献

Matthew Eugene Pipkin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew Eugene Pipkin', 18)}}的其他基金

Nuclear Receptor Networks in Mucosal Immune Regulation
粘膜免疫调节中的核受体网络
  • 批准号:
    10822885
  • 财政年份:
    2023
  • 资助金额:
    $ 67.84万
  • 项目类别:
Nuclear Receptor Networks in Mucosal Immune Regulation
粘膜免疫调节中的核受体网络
  • 批准号:
    10591752
  • 财政年份:
    2021
  • 资助金额:
    $ 67.84万
  • 项目类别:
Nuclear Receptor Networks in Mucosal Immune Regulation
粘膜免疫调节中的核受体网络
  • 批准号:
    10459564
  • 财政年份:
    2021
  • 资助金额:
    $ 67.84万
  • 项目类别:
Nuclear Receptor Networks in Mucosal Immune Regulation
粘膜免疫调节中的核受体网络
  • 批准号:
    10283045
  • 财政年份:
    2021
  • 资助金额:
    $ 67.84万
  • 项目类别:
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
CD4 和 CD8 T 细胞效应及记忆分化和功能的转录因子调节
  • 批准号:
    10488579
  • 财政年份:
    2020
  • 资助金额:
    $ 67.84万
  • 项目类别:
shRNAmir and CRISPR sgRNA Library Construction Core
shRNAmir 和 CRISPR sgRNA 文库构建核心
  • 批准号:
    10591867
  • 财政年份:
    2020
  • 资助金额:
    $ 67.84万
  • 项目类别:
shRNAmir and CRISPR sgRNA Library Construction Core
shRNAmir 和 CRISPR sgRNA 文库构建核心
  • 批准号:
    10024585
  • 财政年份:
    2020
  • 资助金额:
    $ 67.84万
  • 项目类别:
shRNAmir and CRISPR sgRNA Library Construction Core
shRNAmir 和 CRISPR sgRNA 文库构建核心
  • 批准号:
    10224890
  • 财政年份:
    2020
  • 资助金额:
    $ 67.84万
  • 项目类别:
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
CD4 和 CD8 T 细胞效应及记忆分化和功能的转录因子调节
  • 批准号:
    10683256
  • 财政年份:
    2020
  • 资助金额:
    $ 67.84万
  • 项目类别:
Gene expression, Epigenetics and Bioinformatics Core
基因表达、表观遗传学和生物信息学核心
  • 批准号:
    10591868
  • 财政年份:
    2020
  • 资助金额:
    $ 67.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了